Inventor · disambiguated record
Christopher B. Doering
Also filed as: DOERING CHRISTOPHER · DOERING CHRISTOPHER B
13 granted patents·14 pending applications·40 citations·filing 2006–2025
88Inventor score
Files withUNIV EMORY18UNIV WAKE FOREST HEALTH SCIENCES4UNIV KINGSTON2DOERING CHRISTOPHER1EXPRESSION THERAPEUTICS INC1
Top patents by PatentIndex Score
27 records- 0193US10323077B2Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancerUNIV EMORY·Filed 2015·Granted Jun 18, 2019·12 cites·11 claims
- 0289US10654910B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2016·Granted May 19, 2020·7 cites·18 claims
- 0389US10058624B2Recombinant promoters and vectors for protein expression in liver and use thereofUNIV EMORY·Filed 2016·Granted Aug 28, 2018·11 cites·28 claims
- 0486US10724050B1CAS9 nucleic acid molecules and their useUNIV EMORY·Filed 2017·Granted Jul 28, 2020·3 cites·17 claims
- 0582US11046750B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2020·Granted Jun 29, 2021·1 cites·12 claims
- 0681US10898588B2Recombinant promoters and vectors for protein expression in liver and use thereofUNIV EMORY·Filed 2018·Granted Jan 26, 2021·1 cites·18 claims
- 0779US2025101462A1Methods, Devices and Systems for Enhanced Transduction EfficiencyUNIV EMORY·Filed 2024·Application pending·0 cites
- 0873US11897938B2Factor VIII proteins having ancestral sequences, expression vectors, and uses related theretoUNIV EMORY·Filed 2021·Granted Feb 13, 2024·0 cites·9 claims
- 0973US2025034232A1von Willebrand Factor Proteins for Treating Bleeding DisordersUNIV KINGSTON·Filed 2024·Application pending·0 cites
- 1068US12188038B2Methods, devices and systems for enhanced transduction efficiencyUNIV EMORY·Filed 2019·Granted Jan 7, 2025·0 cites·20 claims
- 1167US11136369B2Expression of chimeric polypeptide with variable lymphocyte receptors on immune cells and uses for treating cancerUNIV EMORY·Filed 2019·Granted Oct 5, 2021·0 cites·15 claims
- 1266US11634726B2Cas9 nucleic acid molecules and their useUNIV EMORY·Filed 2020·Granted Apr 25, 2023·0 cites·14 claims
- 1366US2024139253A1Post-Natal Transplantation Of Factor VIII-Expressing Cells For Treatment of HemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2023·Application pending·0 cites
- 1466US2024066067A1In utero transplantation of factor viii-expressing cells for treatment of hemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2023·Application pending·0 cites
- 1566US2021128751A1Recombinant promoters and vectors for protein expression in liver and use thereofUNIV EMORY·Filed 2021·Application pending·0 cites
- 1662US12116399B2Von Willebrand factor proteins for treating bleeding disordersUNIV KINGSTON·Filed 2018·Granted Oct 15, 2024·0 cites·14 claims
- 1759US7482531B2Integrated digital control for stringed musical instrumentDOERING CHRISTOPHER·Filed 2006·Granted Jan 27, 2009·5 cites·22 claims
- 1855US11633504B2Nucleic acids encoding clotting factor variants and their useUNIV EMORY·Filed 2018·Granted Apr 25, 2023·0 cites·11 claims
- 1954US2023374484A1Clotting Factor Variants and Their UseEXPRESSION THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 2053US2020368286A1In utero transplantation of factor viii-expressing cells for treatment of hemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 2153US2020360441A1Post-natal transplantation of factor viii-expressing cells for treatment of hemophiliaUNIV WAKE FOREST HEALTH SCIENCES·Filed 2018·Application pending·0 cites
- 2253US2017198303A1Methods, Devices and Systems for Enhanced Transduction EfficiencyUNIV EMORY·Filed 2016·Application pending·0 cites
- 2351US2022184604A1Methods, Devices and Systems for Enhanced Transduction EfficiencyUNIV EMORY·Filed 2020·Application pending·0 cites
- 2450US2021163989A1Transduction of innate immunocompetent cells using aav6UNIV EMORY·Filed 2019·Application pending·0 cites
- 2548US2025281544A1Gene therapy for bleeding disordersEXPRESSION THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2645US2021393687A1Compositions and methods for treatment of hemophagocytic lymphohistiocytosisUNIV EMORY·Filed 2019·Application pending·0 cites
- 2741US2020179450A1T-cell antigen targeted chimeric antigen receptor (car) and uses in cell therapiesUNIV EMORY·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher B. Doering files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →